Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2008 08:59 ET | Source: Adeona Pharmaceuticals, Inc.

Adeona Pharmaceuticals' Oral dnaJP1 Phase II Clinical Findings Presented At the American College of Rheumatology Annual Meeting

ANN ARBOR, Mich., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
October 28, 2008 08:05 ET | Source: Lazare Kaplan International

Lazare Kaplan International Inc. to Webcast 2008 Annual Meeting of Shareholders

NEW YORK, Oct. 28, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI), a manufacturer and marketer of diamonds and jewelry products, will conduct its annual meeting of shareholders...
October 20, 2008 08:00 ET | Source: Cytomedix, Inc.

Cytomedix to Present At Rodman & Renshaw 10th Annual Healthcare Conference On Wednesday, Nov. 12, 2008

ROCKVILLE, Md., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Chief Executive Officer Martin Rosendale will present an overview of the Company at the Rodman &...
October 16, 2008 08:45 ET | Source: Adeona Pharmaceuticals, Inc.

Pipex Pharmaceuticals, Inc. Completes Corporate Name Change to Adeona Pharmaceuticals and Receives New Ticker Symbol

ANN ARBOR, Mich., Oct. 16, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (the "Company" or "Pipex") (AMEX:PP), a pharmaceutical company developing innovative late-stage oral drug candidates for...
October 14, 2008 16:10 ET | Source: Lazare Kaplan International

Lazare Kaplan International Inc. Announces First Quarter Fiscal 2009 Results

NEW YORK, Oct. 14, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI) today announced financial results for the first fiscal quarter of fiscal 2009 ended August 31, 2008. Net sales...
October 07, 2008 08:29 ET | Source: Adeona Pharmaceuticals, Inc.

Pipex Pharmaceuticals' Oral Flupirtine Receives IRB Approval to Initiate Phase II Clinical Trial for Fibromyalgia

ANN ARBOR, Mich., Oct. 7, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (AMEX:PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
September 19, 2008 13:00 ET | Source: Cytomedix, Inc.

Cytomedix On Track With Sales and Marketing Efforts for AutoloGel System and Further Development of CT-112 Peptide, Annual Meeting Told

ROCKVILLE, Md., Sept. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) Chief Executive Officer Martin Rosendale told the Annual Meeting of Shareholders today that the Company is progressing...
September 10, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development

ROCKVILLE, Md., Sept. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced the appointment of Dr. Peter Anton Clausen, Ph.D., a seasoned biochemist with nearly 15 years experience...
September 08, 2008 16:05 ET | Source: Lazare Kaplan International

Lazare Kaplan International Inc. Reports Fourth Quarter and Fiscal 2008 Year-End Results

NEW YORK, Sept. 8, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI) today announced financial results for the fourth fiscal quarter and year ended May 31, 2008. For the fourth...
September 08, 2008 13:05 ET | Source: Lazare Kaplan International

Lazare Kaplan International Inc. to Webcast Fiscal 2008 Fourth Quarter and Year-End Results

NEW YORK, Sept. 8, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI), a manufacturer and marketer of diamonds and jewelry products, intends to release its fiscal 2008 fourth quarter...